Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
ANI PHARMACEUTICALS INC
| Metric | ANI PHARMACEUTICALS INC ANIPHealthcare |
|---|---|
| Quality Score | 88 / 100 |
| Revenue (latest) | $883M |
| Net income (latest) | $78M |
| Operating margin | 12.6% |
| Net margin | 8.9% |
| Return on equity | 14.5% |
| Return on assets | 5.4% |
| Return on capital (ROCE) | 9.6% |
| Debt / equity | 1.66× |
| Revenue growth (YoY) | 43.8% |
| Altman Z″ (distress) | 3.26 |
| Accruals / assets | −7.4% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.